FDA NDC Directory · JSON-LD · Markdown

amikacin sulfate

NDC 25021-173 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA203323
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsAMIKACIN SULFATE (250 mg/mL)
Marketing started20160615
Package count2

External sources

Source: openFDA. Public-domain (CC0).